Huntington National Bank’s Iovance Biotherapeutics IOVA Stock Holding History

Huntington National Bank’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.02K	Hold	1,146	–	–	﹤0.01%	2117
2025 Q4	$3.13K	Buy	1,146 +1,145	+114,500%	+$2.65K	﹤0.01%	2102
2025 Q3	$2	Hold	1	–	–	﹤0.01%	3964
2025 Q2	$2	Hold	1	–	–	﹤0.01%	3972
2025 Q1	$3	Sell	1 -1,381	-100%	-$7.12K	﹤0.01%	3945
2024 Q4	$10.2K	Sell	1,382 -824	-37%	-$7.64K	﹤0.01%	1772
2024 Q3	$20.7K	Buy	2,206 +1,265	+134%	+$12K	﹤0.01%	1502
2024 Q2	$7.55K	Sell	941 -43	-4%	-$461	﹤0.01%	1790
2024 Q1	$14.6K	Buy	984 +983	+98,300%	+$11.4K	﹤0.01%	1569
2023 Q4	$8	Hold	1	–	–	﹤0.01%	3509
2023 Q3	$5	Buy	+1	New	+$7	﹤0.01%	3572

Other funds holding IOVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MFM

MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Huntington National Bank's IOVA Position: Q1 2026 in Review

Huntington National Bank held its Iovance Biotherapeutics (IOVA) position steady in Q1 2026 at 1,146 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Huntington National Bank first reported a position in IOVA in Q3 2023 and has held it in 11 quarters since. The position peaked at $20.7K in Q3 2024. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

Huntington National Bank held 1,146 shares of Iovance Biotherapeutics worth $4.02K as of Q1 2026.
Huntington National Bank left its Iovance Biotherapeutics share count unchanged in Q1 2026.
Iovance Biotherapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2117 holding.
Huntington National Bank first reported a position in Iovance Biotherapeutics in Q3 2023 and has held it in 11 quarters since.
Huntington National Bank's Iovance Biotherapeutics position peaked at $20.7K in Q3 2024.
285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.